South Korea
Onconic Therapeutics Gains South Korean Approval for Innovative GERD Treatment JAQBO
Onconic Therapeutics, a leading biotechnology company in Korea, announced that the Ministry of Food and Drug Safety (MFDS) of Korea has approved JAQB...
April 26, 2024 | News
Hyundai Bioscience Targets p53 Gene Mutations with Novel Niclosamide-Based Cancer Therapy
The only solution for intractable cancer caused by mutations in the p53 gene Planning clinical trials targeting cancer patients with no available treatm...
April 26, 2024 | News
Samsung Biologics Reports Robust Growth in First Quarter of 2024, Revenue Surges by 31.3%
Recorded Q1'24 consolidated revenue of KRW 946.9 billion Recorded Q1'24 consolidated operating profit of KRW 221.3 billion Sustained growth d...
April 25, 2024 | News
Hanmi Pharmaceutical Partners with MSD to Advance Immuno-Oncology Drug BH3120 in New Clinical Trial
Hanmi Pharmaceutical (KOSPI: 128940, CEO: Jae-Hyun Park), a leading biopharma company in Korea that focuses on research areas such as oncology, obesit...
April 24, 2024 | News
OSR Holdings and SillaJen Forge Strategic Partnership to Enhance Immuno-Oncology Drug Development
OSR Holdings, a global healthcare holding company, announced that it has signed a memorandum of understanding (MOU) with SillaJen, a Kosdaq-listed biotech ...
April 23, 2024 | News
Hyundai Bioscience Launches Clinical Trials for Innovative Niclosamide-Based Cancer Drug
Clinical trials of Niclosamide-based oral metabolic anticancer drug to commence for patients with difficult-to-treat cancers such as triple-negative...
April 23, 2024 | News
Hyundai Bioscience to Conduct Global Clinical Trials for Groundbreaking Dengue Treatment
Hyundai Bioscience CEO Oh Sang-gi, announced its plan to launch global clinical trials for a revolutionary treatment targeting all four serotypes of ...
April 22, 2024 | News
CryptoLab and Macrogen Ink Deal to Integrate Advanced Encryption in Genomic Services
CryptoLab, a pioneer of fully homomorphic encryption (FHE) technology has announced the signing of a three-year supply contract with Macrogen, Korea'...
April 18, 2024 | News
New England Biolabs® Launches New Subsidiary in the Republic of Korea
The Republic of Korea is emerging as a global leader in the life science space, as a result of strong public sector support and private sector investments....
April 04, 2024 | News
Sebastian Arana Discusses Merck's Strategic Expansion in Asia-Pacific Through Innovative Bioprocessing Facility in Daejeon, South Korea
In an illuminating interview with BioPharma APAC, Sebastian Arana, Executive Vice President and Global Head of Process Solutions at Merck, shares insights ...
April 02, 2024 | Interview
Bridge Biotherapeutics Partners with Emory University to Advance Lung Cancer Treatment
Bridge Biotherapeutics (KQ288330), a South Korean clinical-stage biotech company developing novel drugs for cancer, fibrosis, and inflammation, announ...
April 01, 2024 | News
Bridge Biotherapeutics Partners with Emory University to Combat Lung Cancer Resistance
Bridge Biotherapeutics (KQ288330), a South Korean clinical-stage biotech company developing novel drugs for cancer, fibrosis, and inflammation, ...
March 29, 2024 | News
Johnson & Johnson and Korean Health Ministry Launch Accelerator for Biotech & Medtech Startups
Johnson & Johnson Innovation – JLABS (JLABS) will activate its global network to enhance the competitiveness of Korean biotech and medtech startu...
March 29, 2024 | News
Bridge Biotherapeutics Partners with University of Colorado for Cancer Research
Bridge Biotherapeutics (KQ288330), a South Korean clinical-stage biotech company developing novel drugs for cancer, fibrosis, and inflammation, announced a...
March 27, 2024 | News
Most Read
- Biotech and Biopharma Industry Trends: What to Watch for in 2024
- Revolutionizing Drug Discovery: 15 AI Companies to Watch in 2024
- Pioneering Precision: Top 15 Clinical and Lab Diagnostic Companies to Watch in 2024
- 2024's Biopharma Roadmap: Top 24 Biopharma Trends to Watch in 2024
- Breakthroughs Unveiled: A Year of Groundbreaking Novel Drug Approvals in 2023
- Revolutionizing Tomorrow: Top 24 Emerging Biotech Innovations to Watch in 2024
Bio Jobs
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
- Cordlife Accelerates Lab and Technical Staff Recruitment to Rebuild Foundation and Strengthen Core Processes in Singapore
- Padraig McDonnell Takes Helm as Agilent Technologies' New CEO, Pledges to Elevate Scientific Impact
- Agilent Singapore and Malaysia Hosts CEO Transition Event: Celebrating Leadership and Welcoming New CEO
- Leica Microsystems Announces Vacancy for Senior Imaging FPGA Testing Engineer in Singapore
- Glen Godresse Takes Helm as CEO of Menarini Asia-Pacific
News
Editor Picks
